Govt revamps technology upgradation scheme for pharma sector

13 Mar 2024

The union government on Monday announced a revamped scheme of assistance for technology upgradation in the pharmaceuticals sector – a move aimed at ensuring that Indian industries are on par with global standards.

Novartis announces strategic review of its India business

19 Feb 2024

Swiss pharma multinational Novartis AG has started a strategic review of its Indian arm, possibly with the intent of selling it off.

Taro to merge with Sun Pharma in $350 million deal

21 Jan 2024

Sun Pharmaceutical Industries Limited and Israel-based Taro Pharmaceutical Industries Ltd have entered into a definitive merger agreement under which Sun Pharma

LyondellBasell to acquire 35% of Saudi petrochemical company for $500 m

17 Jan 2024

LyondellBasell, a global leader in petrochemicals, today announced the signing of an agreement to acquire a 35 per cent interest in Saudi Arabia–based National Petrochemical Industrial Company (NATPET)

Bristol Myers Squibb to acquire RayzeBio for $4.1 billion in cash

31 Dec 2023

American multinational pharmaceutical company Bristol Myers Squibb on Tuesday said it would buy RayzeBio for about $4.1 billion to bolster its cancer drug business

AstraZeneca to buy China's Gracell Biotechnologies for $1.2 bn

27 Dec 2023

Anglo-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has agreed to acquire China-based Gracell Biotechnologies Inc, for about $1.2 billion.

Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 bn

26 Dec 2023

Bristol Myers Squibb on Friday agreed to acquire Karuna Therapeutics, a pioneer in schizophrenia drugs, for $330 per share in cash

Pfizer is set to acquire Seagen for $43 billion and create a new oncology division

13 Dec 2023

In a significant move, Pfizer has announced its anticipation of concluding the $43 billion deal to acquire cancer drug maker Seagen by 16 December 2023.

Western drugmakers pivot to India as tensions with China prompt supply chain shifts

27 Nov 2023

In a strategic move to reduce dependence on Chinese contractors in drug production, global pharmaceutical companies are turning to Indian manufacturers.

Johnson & Johnson proposes to pay nearly $9 bn to settle lawsuits in US

10 Apr 2023

SCO showcases first international conference and expo on traditional medicine

09 Mar 2023

AstraZeneca to acquire CinCor Pharma in a deal worth $1,8 bn

11 Jan 2023

Eli Lilly to buy gene therapy company Akouos for $487 million

27 Oct 2022

Hetero acquires Johnson & Johnson’s Telangana plant

26 Oct 2022

Torrent Pharma to acquire Curatio Health for Rs2,000 cr

03 Oct 2022

Moderna sues Pfizer-BioNtech for patent violation

02 Sep 2022

According to Moderna, Pfizer-BioNTech copied mRNA technology that Moderna had patented between 2010 and 2016, well before Covid-19 emerged in 2019

Sun Pharma chairman Israel Makov to retire on 29 August

08 Aug 2022

Makov has played a significant role in Sun Pharma’s transformation from a $1.7 billion organisation focusing on India and the US into the world's fourth largest specialty generic pharmaceutical company operating across 100+ markets with a turnover of over $5 billion

Govt invites application for Vitamin B1 manufacturing under revised PLI scheme

01 Aug 2022

Govt to roll out MSMEs and cluster schemes for strengthening pharmaceuticals Industry

19 Jul 2022

Novartis to cut up to 8,000 jobs globally as it restructures business

01 Jul 2022

Glenmark’s nasal spray granted marketing approval in India

16 May 2022

Pfizer to boost respiratory drug portfolio with ReViral purchase

08 Apr 2022

Govt extends application deadline for Bulk Drugs PLI scheme

16 Mar 2022

Gujarat Alkalies, CSIR-IICT co-develops technology to produce super speciality chemical Hydrazine Hydrate

22 Nov 2021

Flipkart to acquire majority stake in Sastasundar to boost healthcare portfolio

12 Nov 2021